What is MOTS-c and how does it differ from other metabolic peptides?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide (MDP) encoded in mitochondrial DNA. Unlike most peptides studied in metabolic research, MOTS-c originates from within cells and translocates to the nucleus under metabolic stress to activate AMPK signaling — a fundamentally different mechanism from receptor-mediated metabolic peptides like AOD-9604.

Are AOD-9604 and MOTS-c approved for human use?

No. Both compounds are research-grade peptides supplied by OmegaCore Research for laboratory investigation only. They are not approved for human consumption. All handling must be conducted by trained personnel in compliance with applicable regulations.

← All Comparisons|Metabolic Peptide Research|Metabolic Research Overview

AOD-9604 vs MOTS-c: Which Is Better for Fat Metabolism Research?

Q: What is the difference between AOD-9604 and MOTS-c?

AOD-9604 is a synthetic C-terminal fragment of human growth hormone studied for lipolytic activity via β3-adrenergic-like receptor pathways without binding the GH receptor. MOTS-c is a mitochondria-derived peptide that activates AMPK to regulate glucose utilization and energy homeostasis at the cellular level. These represent distinct approaches to studying fat metabolism.

Q: Why compare AOD-9604 and MOTS-c in metabolic research?

Both compounds modulate fat metabolism but through complementary mechanisms — AOD-9604 acts peripherally on adipose tissue lipolysis, while MOTS-c acts systemically through mitochondrial AMPK signaling. Researchers compare them to study how different cellular entry points into energy regulation produce distinct and potentially complementary metabolic effects.

Q: Does AOD-9604 bind the growth hormone receptor?

No. A key distinguishing characteristic of AOD-9604 is that it does not bind the GH receptor (GHR) and therefore does not activate IGF-1 axis signaling. Its lipolytic activity operates through a separate β3-adrenergic-like pathway, making it a selective adipose tissue research tool without GH receptor-related off-target effects.

Last updated: April 25, 2026

AOD-9604 vs MOTS-c is compared in fat metabolism research to contrast peripheral lipolytic signaling via beta-3 adrenergic receptors against intracellular AMPK activation from mitochondrial peptide signaling.

AOD-9604 vs MOTS-c: Quick Answer

AOD-9604 is preferred for adipose-focused lipolysis studies without GH receptor involvement, while MOTS-c is used for mitochondrial AMPK signaling and energy homeostasis research.

Choose AOD-9604 for:

→Adipose tissue lipolysis studies via beta-3 adrenergic pathways
→GH-independent fat metabolism without IGF-1 axis effects
→Peripheral adipose biology in fat mobilization models

Choose MOTS-c for:

→Intracellular AMPK activation and energy sensing
→Mitochondrial biogenesis and glucose metabolism research
→Insulin sensitivity and skeletal muscle metabolic studies

This guide compares AOD-9604 vs MOTS-c, also searched as MOTS-c vs AOD-9604, for researchers studying complementary mechanisms of metabolic peptide research.

This guide compares AOD-9604 vs MOTS-c, examining research differences in peptide origin, lipolytic vs. mitochondrial mechanisms, and metabolic pathway activity. AOD-9604 stimulates adipose tissue lipolysis without GH receptor binding; MOTS-c activates AMPK through mitochondrial signaling. See also MOTS-c vs AOD-9604 and the metabolic research overview.

Key Differences at a Glance

→GH C-terminal fragment (lipolysis via β3-adrenergic pathway) vs. mitochondria-derived AMPK activator
→AOD-9604 does not bind the GH receptor — no IGF-1 axis activation
→MOTS-c translocates to nucleus under metabolic stress for AMPK-mediated energy regulation
→Research focus: adipose tissue lipolysis (AOD-9604) vs. mitochondrial biogenesis/glucose regulation (MOTS-c)

AOD-9604 and MOTS-c are complementary metabolic peptides studied at different cellular levels of energy regulation. AOD-9604 acts peripherally on adipose tissue; MOTS-c acts intracellularly via mitochondrial AMPK signaling. Their comparison illuminates the mechanistic diversity of peptide-based metabolic research tools. For longevity context, see best peptides for longevity research.

AOD-9604 vs MOTS-c: At a Glance

Characteristic	AOD-9604	MOTS-c
Peptide Origin	GH C-terminal fragment (hGH 177–191)	Mitochondrial 12S rRNA (MDP)
Molecular Weight	~1,815 Da	~2,174 Da
Primary Mechanism	β3-adrenergic-like lipolytic signaling	AMPK activation, glucose/lipid homeostasis
GH Receptor Binding	Does not bind GH receptor	N/A — nuclear/cytoplasmic target
IGF-1 Axis Effect	None (no GHR binding)	Studied in mitochondrial context
Primary Research Focus	Adipose tissue lipolysis, fat metabolism	Mitochondrial biogenesis, energy regulation
Cellular Location	Extracellular receptor-mediated	Translocates to nucleus under metabolic stress

Recommended for this research

AOD-9604

Research-grade · HPLC verified · Certificate of Analysis included

View Research Grade AOD-9604 →

Research Context

AOD-9604 and MOTS-c are studied at complementary levels of metabolic regulation — extracellular adipose tissue signaling (AOD-9604) and intracellular mitochondrial energy regulation (MOTS-c). Their mechanistic differences make them relevant to different experimental models and research questions within fat metabolism and energy homeostasis research. For broader metabolic peptide context, see the metabolic research overview.

What Is AOD-9604?

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment corresponding to amino acids 177–191 of the C-terminus of human growth hormone. Developed to isolate GH's lipolytic properties without its growth-promoting anabolic effects, AOD-9604 does not bind the GH receptor (GHR) and therefore produces no IGF-1 axis activation — a critical distinguishing characteristic from intact growth hormone research.

Research indicates AOD-9604 stimulates lipolysis in adipose tissue through a β3-adrenergic-like receptor pathway, promoting fatty acid release from fat cells without the IGF-1 or insulin-related signaling confounders associated with GH receptor activation. This selective lipolytic activity makes AOD-9604 a specific research tool for adipose tissue biology and fat metabolism pathway studies.

What Is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide (MDP) encoded within the 12S ribosomal RNA gene of mitochondrial DNA. Unlike most research peptides, MOTS-c is of intracellular, organellar origin — a discovery that established a new class of bioactive peptides originating from mitochondria. Research suggests MOTS-c may represent an endogenous metabolic stress response signal.

Research indicates MOTS-c translocates from mitochondria to the nucleus under conditions of metabolic stress (such as glucose restriction or exercise), where it activates AMPK signaling pathways to enhance glucose utilization, promote fatty acid oxidation, and support mitochondrial biogenesis. This positions MOTS-c as a relevant compound in longevity, metabolic, and mitochondrial function research. For longevity context, see best peptides for longevity research.

Mechanism Comparison: Lipolysis vs Mitochondrial AMPK

AOD-9604: Peripheral Lipolytic Signaling

AOD-9604 activates β3-adrenergic-like receptor pathways in adipose tissue to stimulate lipolysis — fat cell breakdown and fatty acid release. Its mechanism is extracellular, receptor-mediated, and specific to adipose tissue without GHR or IGF-1 axis involvement. Research uses AOD-9604 to study selective adipose tissue lipolytic signaling.

MOTS-c: Intracellular AMPK Activation

MOTS-c activates AMPK — the cellular energy sensor — to regulate glucose utilization, fatty acid oxidation, and mitochondrial biogenesis. Its mechanism is intracellular and nuclear, originating from mitochondrial stress signaling rather than extracellular receptor engagement. Research uses MOTS-c to study mitochondrial-nuclear communication in energy homeostasis.

The distinction between AOD-9604's peripheral adipose targeting and MOTS-c's intracellular mitochondrial signaling illustrates the mechanistic diversity of metabolic peptide research. These compounds can be studied in parallel to understand complementary layers of energy regulation — from adipose tissue lipid mobilization to mitochondrial fuel utilization. See MOTS-c vs AOD-9604 for the reverse-perspective comparison.

Best Use Cases

AOD-9604 is best for:

→Adipose lipolysis via beta-3 adrenergic receptor pathway
→GH-independent fat mobilization research
→Peripheral adipose tissue biology without IGF-1 axis effects
→Studying GH C-terminal fragment activity vs. full-length GH

MOTS-c is best for:

→Intracellular AMPK activation and energy sensing
→Mitochondrial biogenesis and mitochondria-derived peptide research
→Glucose uptake, insulin sensitivity, and skeletal muscle metabolism
→MDP class signaling and mitochondrial-nuclear cross-talk

Which Is Better Overall?

AOD-9604 is better for peripheral adipose lipolysis studies; MOTS-c is better for intracellular AMPK/mitochondrial research. The two compounds address different metabolic levels.

The better choice depends on the research objective:

→Adipose tissue fat mobilization study → AOD-9604
→AMPK and mitochondrial energy research → MOTS-c
→GH-independent lipolysis without GHR activation → AOD-9604
→Glucose uptake and insulin sensitivity models → MOTS-c

Related Comparisons

→ MOTS-c vs AOD-9604 → Tirzepatide vs Semaglutide → Epithalon vs GHK-Cu

Expand Your Research Toolkit

→ Best Peptides for Fat Loss Research → Best Peptides for Longevity Research → Metabolic Research Overview → MOTS-c vs AOD-9604 → Complete Peptide Catalog → Peptides by Research Goal → All Peptide Comparisons Hub

Research Compounds

Shop Research Grade Peptides

→ Metabolic Peptide Catalog View Full Catalog →

Frequently Asked Questions

What is the difference between AOD-9604 and MOTS-c?

AOD-9604 is a GH C-terminal fragment studied for lipolytic activity via β3-adrenergic-like pathways without GH receptor binding. MOTS-c is a mitochondria-derived AMPK activator that translocates to the nucleus under metabolic stress. They represent distinct cellular entry points into fat metabolism research. See MOTS-c vs AOD-9604 for the complementary comparison.

Does AOD-9604 bind the growth hormone receptor?

No. AOD-9604 does not bind GHR and therefore does not activate IGF-1 axis signaling — a key characteristic that differentiates it from intact GH in research models. Its lipolytic activity operates through a β3-adrenergic-like receptor pathway specific to adipose tissue.

How does MOTS-c differ from other metabolic peptides?

MOTS-c is unique in that it originates from mitochondrial DNA — making it a mitochondria-derived peptide (MDP) rather than a synthetic fragment. Under metabolic stress, MOTS-c translocates from mitochondria to the nucleus and activates AMPK signaling to regulate glucose and lipid metabolism. This intracellular origin distinguishes MOTS-c from receptor-targeted metabolic peptides like AOD-9604.

Why compare AOD-9604 and MOTS-c in metabolic research?

Both compounds target fat metabolism through complementary mechanisms — peripheral adipose lipolysis (AOD-9604) vs. mitochondrial energy regulation (MOTS-c). Studying them together provides a more complete picture of the mechanistic diversity available in peptide-based metabolic research. See the metabolic research overview for broader context.

Are these compounds approved for human use?

No. Both are research-grade peptides for laboratory investigation only. Not approved for human consumption. All handling must be conducted by trained personnel in compliance with applicable regulations.

Trust OmegaCore for Research-Grade Compounds

OmegaCore Research provides pharmaceutical-grade peptides independently verified through HPLC analysis. Every batch includes a Certificate of Analysis documenting purity, sequence confirmation, and handling specifications.

View Metabolic Peptide Catalog →

Research Use Only

This content is for educational and informational purposes within the research community. AOD-9604 and MOTS-c are intended for laboratory research use only and are not approved for human consumption. All handling must be conducted by trained personnel in appropriate laboratory settings in compliance with applicable regulations.